Viewing Study NCT05239169

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-05-14 @ 1:57 PM
Study NCT ID: NCT05239169
Status: COMPLETED
Last Update Posted: 2025-05-01
First Post: 2021-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Cancer (CCA) View
None Intrahepatic Cholangiocarcinoma View
None Hilar Cholangiocarcinoma View
None Distal Cholangiocarcinoma View
None Gall Bladder Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Biliary Tract Cancer View
None CCA View